Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +40.55%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +31.36%
#6 Humanity Humanity +26.19%
#7 Enso Enso +16.12%
#8 Tutorial Tutorial +16.11%
#9 Velvet Velvet +15.00%
#10 Codatta Codatta +14.73%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Bacil Pharma Limited Bacil Pharma Limited

Bacil Pharma Limited

BACPHAR
Rank in Stocks #37044
Bacil Pharma Limited operates as a specialist in the production and... Bacil Pharma Limited operates as a specialist in the production and distribution of a diverse range of pharmaceutical, therapeutic, and botanical goods. Their primary manufacturing facility, situated in Lote-Parshuram, is additionally equipped for the processing of herbal extracts and the synthesis of drug intermediates. The company was established on May 8, 1987, and its corporate headquarters are located in Mumbai, India.
Share Price
$0.14479071
Last synced: 2026-08-14
Market Cap
$2.08M
Change (1 day)
-5.00%
Change (1 year)
-66.15%
Country
IN
Trade Bacil Pharma Limited (BACPHAR)

Category

Healthcare
P/E ratio for Bacil Pharma Limited (BACPHAR)
P/E ratio as of 2026 TTM: 0
According to Bacil Pharma Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Bacil Pharma Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.13 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.